Immune mediated disorders in women with a fragile X expansion and FXTAS

Isha Jalnapurkar, Nuva Rafika, Flora Tassone, Randi J Hagerman

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Premutation alleles in fragile X mental retardation 1 (FMR1) can cause the late-onset neurodegenerative disorder, fragile X-associated tremor ataxia syndrome (FXTAS) and/or the fragile X-associated primary ovarian insufficiency in approximately 20% of heterozygotes. Heterozygotes of the FMR1 premutation have a higher incidence of immune mediated disorders such as autoimmune thyroid disorder, especially when accompanied by FXTAS motor signs. We describe the time course of symptoms of immune mediated disorders and the subsequent development of FXTAS in four women with an FMR1 CGG expansion, including three with the premutation and one with a gray zone expansion. These patients developed an immune mediated disorder followed by neurological symptoms that become consistent with FXTAS. In all patients we observed a pattern involving an initial appearance of disease symptoms-often after a period of heightened stress (depression, anxiety, divorce, general surgery) followed by the onset of tremor and/or ataxia. Immune mediated diseases are associated with the manifestations of FXTAS temporally, although further studies are needed to clarify this association. If a cause and effect relationship can be established, treatment of pre-existing immune mediated disorders may benefit patients with pathogenic FMR1 mutations.

Original languageEnglish (US)
Pages (from-to)190-197
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume167
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Immune System Diseases
Intellectual Disability
Heterozygote
Primary Ovarian Insufficiency
Divorce
Tremor
Ataxia
Neurodegenerative Diseases
Thyroid Gland
Anxiety
Alleles
Fragile X Tremor Ataxia Syndrome
Depression
Mutation
Incidence

Keywords

  • Autoimmune disease
  • CGG repeat
  • FMR1 gene
  • FXTAS
  • Genetic counseling
  • Premutation
  • RNA toxicity

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Immune mediated disorders in women with a fragile X expansion and FXTAS. / Jalnapurkar, Isha; Rafika, Nuva; Tassone, Flora; Hagerman, Randi J.

In: American Journal of Medical Genetics, Part A, Vol. 167, No. 1, 01.01.2015, p. 190-197.

Research output: Contribution to journalArticle

@article{13e0ad5d74f34f01af7a1dc4438a9590,
title = "Immune mediated disorders in women with a fragile X expansion and FXTAS",
abstract = "Premutation alleles in fragile X mental retardation 1 (FMR1) can cause the late-onset neurodegenerative disorder, fragile X-associated tremor ataxia syndrome (FXTAS) and/or the fragile X-associated primary ovarian insufficiency in approximately 20{\%} of heterozygotes. Heterozygotes of the FMR1 premutation have a higher incidence of immune mediated disorders such as autoimmune thyroid disorder, especially when accompanied by FXTAS motor signs. We describe the time course of symptoms of immune mediated disorders and the subsequent development of FXTAS in four women with an FMR1 CGG expansion, including three with the premutation and one with a gray zone expansion. These patients developed an immune mediated disorder followed by neurological symptoms that become consistent with FXTAS. In all patients we observed a pattern involving an initial appearance of disease symptoms-often after a period of heightened stress (depression, anxiety, divorce, general surgery) followed by the onset of tremor and/or ataxia. Immune mediated diseases are associated with the manifestations of FXTAS temporally, although further studies are needed to clarify this association. If a cause and effect relationship can be established, treatment of pre-existing immune mediated disorders may benefit patients with pathogenic FMR1 mutations.",
keywords = "Autoimmune disease, CGG repeat, FMR1 gene, FXTAS, Genetic counseling, Premutation, RNA toxicity",
author = "Isha Jalnapurkar and Nuva Rafika and Flora Tassone and Hagerman, {Randi J}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/ajmg.a.36748",
language = "English (US)",
volume = "167",
pages = "190--197",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Immune mediated disorders in women with a fragile X expansion and FXTAS

AU - Jalnapurkar, Isha

AU - Rafika, Nuva

AU - Tassone, Flora

AU - Hagerman, Randi J

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Premutation alleles in fragile X mental retardation 1 (FMR1) can cause the late-onset neurodegenerative disorder, fragile X-associated tremor ataxia syndrome (FXTAS) and/or the fragile X-associated primary ovarian insufficiency in approximately 20% of heterozygotes. Heterozygotes of the FMR1 premutation have a higher incidence of immune mediated disorders such as autoimmune thyroid disorder, especially when accompanied by FXTAS motor signs. We describe the time course of symptoms of immune mediated disorders and the subsequent development of FXTAS in four women with an FMR1 CGG expansion, including three with the premutation and one with a gray zone expansion. These patients developed an immune mediated disorder followed by neurological symptoms that become consistent with FXTAS. In all patients we observed a pattern involving an initial appearance of disease symptoms-often after a period of heightened stress (depression, anxiety, divorce, general surgery) followed by the onset of tremor and/or ataxia. Immune mediated diseases are associated with the manifestations of FXTAS temporally, although further studies are needed to clarify this association. If a cause and effect relationship can be established, treatment of pre-existing immune mediated disorders may benefit patients with pathogenic FMR1 mutations.

AB - Premutation alleles in fragile X mental retardation 1 (FMR1) can cause the late-onset neurodegenerative disorder, fragile X-associated tremor ataxia syndrome (FXTAS) and/or the fragile X-associated primary ovarian insufficiency in approximately 20% of heterozygotes. Heterozygotes of the FMR1 premutation have a higher incidence of immune mediated disorders such as autoimmune thyroid disorder, especially when accompanied by FXTAS motor signs. We describe the time course of symptoms of immune mediated disorders and the subsequent development of FXTAS in four women with an FMR1 CGG expansion, including three with the premutation and one with a gray zone expansion. These patients developed an immune mediated disorder followed by neurological symptoms that become consistent with FXTAS. In all patients we observed a pattern involving an initial appearance of disease symptoms-often after a period of heightened stress (depression, anxiety, divorce, general surgery) followed by the onset of tremor and/or ataxia. Immune mediated diseases are associated with the manifestations of FXTAS temporally, although further studies are needed to clarify this association. If a cause and effect relationship can be established, treatment of pre-existing immune mediated disorders may benefit patients with pathogenic FMR1 mutations.

KW - Autoimmune disease

KW - CGG repeat

KW - FMR1 gene

KW - FXTAS

KW - Genetic counseling

KW - Premutation

KW - RNA toxicity

UR - http://www.scopus.com/inward/record.url?scp=84919868162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919868162&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.36748

DO - 10.1002/ajmg.a.36748

M3 - Article

C2 - 25399540

AN - SCOPUS:84919868162

VL - 167

SP - 190

EP - 197

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 1

ER -